4 Results

People

  1. Abdel-Wahab
    Abdel-Wahab
  2. Benezra
    Benezra
  3. Henke
    Henke
  4. Levine
    Levine
  5. Scheinberg
    Scheinberg
  6. Thompson
    Thompson
  7. Bhagwat
    Bhagwat
  8. Blasberg
    Blasberg
  9. Escorcia
    Escorcia
  10. Ghosh
    Ghosh

Groups

  1. Adult Leukemia (4)
  2. Cancer Biology and Genetics Program Faculty (4)
  3. Center for Hematologic Malignancies (4)
  4. Department of Medicine (4)
  5. GSK Faculty (4)
  6. Hematologic Malignancies Research (4)
  7. Hematologic Malignancies, Division of (4)
  8. Sloan Kettering Institute Faculty (4)
  9. Tow Center for Developmental Oncology (TCDO) (4)
  10. Executive Committee, Center for Hematologic Malignancies (3)
  1. "Hematologic Malignancies Research"
  2. "Cancer Biology and Genetics Program Faculty"
  3. "2010"
Formats
  1. Journal Article (4)
Groups
  1. Adult Leukemia (4)
  2. Cancer Biology and Genetics Program Faculty (4)
  3. Center for Hematologic Malignancies (4)
  4. Department of Medicine (4)
  5. GSK Faculty (4)
  6. Hematologic Malignancies Research (4)

More Groups

People
  1. Craig Thompson (2)
  2. David Scheinberg (2)
  3. Erik Henke (2)
  4. Omar Abdel-Wahab (2)
  5. Robert Benezra (2)
  6. Ross Levine (2)

More People

Years
  1. 2010 (4)
Publications
  1. Cancer Cell (2)
  2. Cancer Research (1)
  3. JNCI: Journal of the National Cancer Institute (1)
Publishers
  1. Cell Press (2)
  2. American Association for Cancer Research (1)
  3. Oxford University Press (1)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate
    Journal Article

    Ward, P. S.; Patel, J.; Wise, D. R.; Abdel-Wahab, O.; Bennett, B. D.; Coller, H. A.; Cross, J. R.; Fantin, V. R.; Hedvat, C. V.; Perl, A. E.; more...
    Cancer Cell (2010)

    Fulltext@MSK | Save
  • Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth
    Journal Article

    Penack, O.; Henke, E.; Suh, D.; King, C. G.; Smith, O. M.; Na, I. K.; Holland, A. M.; Ghosh, A.; Lu, S. X.; Jenq, R. R.; more...
    JNCI: Journal of the National Cancer Institute (2010)

    Fulltext@MSK | Save
  • Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation
    Journal Article

    Figueroa, M. E.; Abdel-Wahab, O.; Lu, C.; Ward, P. S.; Patel, J.; Shih, A.; Li, Y.; Bhagwat, N.; Vasanthakumar, A.; Fernandez, H. F.; more...
    Cancer Cell (2010)

    Fulltext@MSK | Save
  • Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumors
    Journal Article

    Escorcia, F. E.; Henke, E.; McDevitt, M. R.; Villa, C. H.; Smith-Jones, P.; Blasberg, R. G.; Benezra, R.; Scheinberg, D. A.
    Cancer Research (2010)

    Fulltext@MSK | Save